气相色谱-质谱法测定化妆品中苯酚和氢醌

建立了气相色谱-质谱联用测定化妆品中苯酚和氢醌的检测方法.用甲醇作为提取试样,经HP-INNOWAX毛细管色谱柱分离,选择特征离子监测扫描模式(SIM)测定.结果表明:苯酚的方法线性范围为0.01~50μg/m L(r=0.999 96),检出限为0.05μg/g,加标回收率为91.3%~99.6%,相对标准偏差为1.5%~6.0%.氢醌的方法线性范围为0.02~50μg/m L(r=0.999 87),检出限为0.10μg/g,加标回收率为91.5%~99.7%,相对标准偏差为3.2%~5.5%.方法简单、快速、灵敏,可有效消除化妆品基质的干扰,适用于化妆品中苯酚和氢醌的定性、定量测定.     

葡萄酒中痕量木塞污染物的顶空固相微萃取-气相色谱串联质谱法检测

建立了顶空固相微萃取-气相色谱串联质谱检测葡萄酒中主要的痕量木塞污染物——2,4,6-三氯苯甲醚（TCA）的方法。通过优化萃取时间、温度、盐浓度、pH值等固相微萃取处理条件,采用2,4,6-三氯甲苯（TCT）为内标进行定量,气相色谱离子阱质谱法测定。选取TCA母离子和子离子分别为m/z210和m/z195,TCT的母离子和子离子为m/z195和m/z159。方法的定量下限（LOQ）为2.0 ng/L,回收率为71%-98%。该法操作简单、快速,适用于葡萄酒中痕量TCA残留的快速检测。     

气质联用单离子监测法测定纺织品中1-萘胺和2-萘胺

采用气质联用单离子监测法(SIM)测定纺织品中1-萘胺和2-萘胺，对提取条件进行了优化，采用保留时间和全扫描质谱图定性，特征离子m/z143为监测离子，以其峰面积定量。     

液相色谱-质谱法测定人体血浆中非那雄胺含量

建立了测定人体血浆中非那雄胺药物浓度的液相色谱-质谱分析方法。色谱柱为Hypersil-Keystone C_(18)柱,流动相为乙腈∶水(含0.2%三氯乙酸)=55∶45(V/V),质谱选择电喷雾正离子源(ESI+),选择离子模式(SIM)监测,非那雄胺和内标卡马西平质荷比分别为m/z373和m/z237。血浆样品经乙腈去蛋白、离心和吹干后,残渣用流动相溶解。当非那雄胺的浓度在0.5~120ng·mL~(-1)范围时线性关系良好(r=0.999),检测限(S/N=3)为0.02ng·mL~(-1);日间和日内测定的精密度(RSD)分别在6.4%~2.2%和5.5%~1.7%之间;加标0.5ng·mL~(-1)、40ng·mL~(-1)和80ng·mL~(-1)非那雄胺的平均回收率(n=6)分别为108.5%、101.2%和98.7%。方法快速、准确和灵敏,已成功用于人血浆中非那雄胺浓度的测定和人体药代动力学研究。     

SPE-HPLC-MS定量法测定果蔬中农药马拉硫磷残留量

建立了SPE-HPLC-MS法定量测定果蔬中农药马拉硫磷残留量。固相萃取小柱为SupelcleanTM ENVITM-18柱（3 mL）,丙酮为洗脱液;色谱柱为安捷伦快速高分离亚二微米液相色谱柱Zorbax RRHTSB-C18（1.8μm,4.6 mmi.d.×50mm,Agilent）;流动相为70%甲醇（含2 mmoL甲酸铵）＋30%水,等梯度洗脱;质谱采用正离子电离方式,选择m/z 283和m/z 243碎片离子为定性离子,以丰度最高的碎片离子m/z 283为定量离子,用MRM模式监测;外标法定量。方法相关系数r2=0.9968,检出限（LOD）为0.002 mg/kg,加标回收率为78.3%-96.2%,相对标准偏差（RSD）为3.5%-18.8%,适合样品中低含量马拉硫磷残留量的测定。     

衍生化-离子阱气相色谱质谱联用检测乳粉中三聚氰胺时不同质谱检测方法研究

利用N,O-双三甲基硅基三氟乙酰胺(BSTFA)和三甲基氯硅烷(TMCS)衍生化试剂对乳粉中三聚氰胺进行衍生化处理,利用离子阱气相色谱质谱联用仪,建立了全扫描、选择离子监测、二级质谱3种测定三聚氰胺的质谱方法.选择离子监测以三聚氰胺衍生物的特征离子m/z342,327,171,99为定性离子,以m/z327为定量离子;全扫描法二级质谱特征峰为定性依据,以特征离子m/z327为定量离子;二级质谱法以衍生物二级质谱m/z285,171,213为定性离子,以m/z 285为定量离子.3种方法的线性范围为0.05～2.0 mg/L,线性相关系数分别为0.9986、0.9990、0.9988;检测限分别为0.005、0.002、0.003 mg/kg,RSD分别为6.3%、5.7%、6.1%(n=6),方法的回收率为84%～105%.3种不同质谱检测方法应用到乳粉的检测中效果良好,均能够满足乳粉中三聚氰胺的检测要求.     

GC/MS SIM法快速测定酒中的游离脂肪酸

本文介绍一种简单、快速、灵敏、直接分析酒中游离脂肪酸的测定方法。用涂有OV-17熔融石英毛细管柱。选择游离脂肪酸质谱图中的基峰离子m/z 60进行SIM检测。定量测定了茅台酒、珍酒及鸭溪窖酒中十二种游离脂肪酸。     

气相色谱-质谱联用测定富营养化水体中的异味物质

通过固相微萃取富集,并采用气相色谱-质谱联用(GC-MS)测定了水中常见的两种异味化合物,即2-甲基异茨醇(2-MIB)、土味素(GSM),并对富营养化水体中的挥发性物质进行了初步分析。不同的异味物质吸附于75μm Carboxen/PDMS纤维涂层处理后,通过DB-WAX毛细管色谱柱得以分离。采用选择离子监测模式(SIM)对两种化合物(2-MIBm/z=95,GSMm/z=112)进行外标法定量分析,从而提高检测灵敏度。线性范围2-MIB为0.5~500 ng.L-1、GSM为1.0~500 ng.L-1,检出限分别为0.1,0.4 ng.L-1。用该法对富营养化水源水监测,2-MIB及GSM的分析结果的RSD值及加标回收率为3.35%,7.68%和105.0%,88.3%。     

气相色谱-质谱法测定聚醚砜奶瓶中二苯砜的含量及迁移量

采用气相色谱-质谱联用仪(GC-MS)对聚醚砜(PES)奶瓶中的二苯砜进行定性确证和定量分析。样品粉碎并用三氯甲烷超声溶解后,用乙腈沉淀树脂。选用HP-5MS色谱柱并使用选择离子扫描(SIM)模式进行定性和定量分析。定性离子为m/z77、97、125和218,定量离子为m/z125。二苯砜的线性范围为0.1～100mg/L,仪器的定量检出限为0.004mg/L。奶瓶样品中二苯砜的加标回收率为91%～113%,相对标准偏差(RSD)小于7.7%。将奶瓶进行迁移实验后,水、酸性和油性食品模拟物分析的加标回收率分别为88%～102%、96%～111%和89%～110%,RSD分别为5.2%、5.4%和8.7%。     

超高效液相色谱-串联质谱法测定鲜切杏鲍菇中4-己基间苯二酚的含量

采用超高效液相色谱-串联质谱法测定了鲜切杏鲍菇中4-己基间苯二酚的含量。试样经乙腈超声萃取,SPE-C18柱净化后,UPLC BEH C18色谱柱分离,选择离子监测(SIM),定性离子对(m/z):194.2/123.0;定量离子对(m/z):194.2/67.1,外标法定量。加标回收率在87.6%~93.6%之间,相对标准偏差不大于2.2%;以信噪比RSN=10计算,检出限为10.0μg/kg。     

高效液相色谱-二级管阵列检测器法测定美白类、祛斑类化妆品和香波中氢醌、苯酚含量

样品用甲醇超声提取15 min,离心、过滤,以Agilent ZORBAX Eclipse XDB - CN分析柱分离分析,二级管阵列检测器检测,外标法定量.氢醌、苯酚分别在7.920～79.920 mg/L、9.696～96.960 mg/L浓度范围内线性关系良好,相关系数r =0.99999.氢醌、苯酚在15.84...     

Tenax采样管富集气相色谱-质谱法测定空气中的痕量酚类化合物

建立了Tenax采样管富集气相色谱-质谱测定空气中痕量酚类化合物的方法。用Tenax采样管吸附环境空气中的痕量酚类化合物,用甲醇淋洗解吸酚类化合物,洗脱液加入萘-D8作为内标,利用气相色谱-选择离子监测质谱(GC-MS/SIM)进行检测,内标法定量。该方法定性、定量准确,线性响应良好,回归曲线的线性相关系数均大于0.999,平均回收率为92.4%～102%,测定干扰小,检测灵敏度高,按采样10 L计算,空气中最低检测浓度可达0.001 mg/m3。用于实际样品测定,完全能满足环境空气中痕量酚类化合物监测的要求。     

气相色谱/负离子化学电离质谱法测定土壤中硫丹及其代谢物

采用气相色谱/负离子化学电离质谱法测定土壤中的硫丹及其代谢物。外标法定量,α-硫丹、β-硫丹及硫丹硫酸酯在0.20～10.0 μg/L范围内线性良好,方法检出限分别为0.02、0.02、0.03 μg/Kg,空白加标平行测定的RSD为3.6%～4.3%,土壤样品加标回收率为83.6%～86.4%。本方法定性定量准确,适用于土壤中硫丹的测定。     

串联固相萃取-液相色谱-串联质谱法测定食品中嘧啶胺类杀菌剂残留

建立了食品中嘧啶胺类杀菌剂嘧霉胺、嘧菌胺及嘧菌环胺残留的串联固相萃取-液相色谱-串联质谱(HPLC-MS/MS)检测方法。胡萝卜、辣椒等样品经乙酸乙酯提取,石墨化炭黑-弗罗里硅藻土串联固相萃取柱(ENVI-Carb-Florisil SPE)净化后,在HPLC-MS/MS仪上进行检测分析,采用外标法定量。质谱分析采用电喷雾电离,正离子扫描,多反应监测模式。结果表明,柱净化后无明显的基质效应,嘧霉胺、嘧菌胺和嘧菌环胺在1～20 μg/L内相关系数可达0.9990以上,具有良好的线性关系;每种杀菌剂选择两个离子对,其中一组用于定量: 嘧霉胺m/z 200.1/107.1,嘧菌胺m/z 224.0/106.0及嘧菌环胺m/z 226.0/108.1;另一组用于确证: 嘧霉胺m/z 200.1/183.1,嘧菌胺m/z 224.0/131.1和嘧菌环胺m/z 226.0/133.1。样品中添加0.1、0.5、1.0 μg/kg的标准品,其回收率为73.2%～98.7%,相对标准偏差(n=10)小于10%;嘧霉胺、嘧菌胺、嘧菌环胺的检出限(信噪比(S/N)=3)均为0.03 μg/kg;嘧霉胺、嘧菌胺、嘧菌环胺的定量限(S/N=10)均为0.1 μg/kg。实验结果表明,该方法提取效果好,具有良好的灵敏度、回收率和重复性。     

凝胶渗透色谱柱去脂-气相色谱-质谱法测定人血清中新型卤系阻燃剂

建立了凝胶渗透色谱(GPC)去脂,气相色谱-负化学电离源-质谱(GC-NCI-MS)法测定人血清中2,2’,4,4’,5,5’-六溴联苯(BB-153)、1,2-二(2,4,6-三溴苯氧基)乙烷(BTBPE)和德克隆(Dechlorane plus,DP,包括syn-DP和anti-DP)的方法。人血清样本加入内标13C12BB-153和13C10syn-DP,经蛋白质变性、脂肪提取、GPC去脂、酸性硅胶柱净化后,利用气相色谱-负化学电离源-质谱法测定样品中BB-153,BTBPE,syn-DP和anti-DP,监测离子分别为m/z 627.5,629.5,m/z 79,81以及m/z 652,654。结果表明,13 C12 BB-153和13 C10syn-DP的血清加标回收率分别为91.5%±8.9%和92.3%±8.1%,检出限为0.6～1.2 ng/g脂肪。应用本方法对人血样品进行测定,BB-153和BTBPE在所有样本中均未检出,syn-DP和anti-DP的浓度范围分别是0.7～9.2 ng/g脂肪和0.6～2.0 ng/g脂肪。     

Simultaneous quantitation of nicorandil and its denitrated metabolite in plasma by LC-MS/MS: application for a pharmacokinetic study

A liquid chromatography-electrospray ionization tandem mass spectrometry method was developed and validated for the simultaneous quantitation of nicorandil and its denitrated metabolite, N-(2-hydroxyethyl)-nicotinamide, in rat plasma. After a liquid-liquid extraction step, chromatographic separation was performed on a ShinPack C(18) column with an isocratic mobile phase composed of methanol and 2 mM aqueous ammonium acetate containing 0.03% (v/v) formic acid (33:67 v/v). Procainamide was used as an internal standard (IS). Selected reaction monitoring was performed using the transitions m/z 212 → m/z 135, m/z 166 → m/z 106 and m/z 236 → m/z 163 to quantify nicorandil, its denitrated metabolite and IS, respectively. Calibration curves were constructed over the range of 5-15,000 ng.ml(-1) for both nicorandil and its metabolite. The mean relative standard deviation (RSD%) values for the intra-run precision were 5.4% and 7.3% and for the inter-run precision were 8.5% and 7.3% for nicorandil and its metabolite, respectively. The mean accuracy values were 100% and 95% for nicorandil and its metabolite, respectively. No matrix effect was detected in the samples. The validated method was successfully applied to a pharmacokinetic study after per os administration of nicorandil in rats.     

Simultaneous quantification of fexofenadine and pseudoephedrine in human plasma by liquid chromatography/tandem mass spectrometry with electrospray ionization: method development, validation and application to a clinical study

To support the pharmacokinetic and bioavailability study of a once-daily fexofenadine/pseudoephedrine combination, a high-performance liquid chromatography/positive ion electrospray tandem mass spectrometry (HPLC/ESI-MS/MS) method for the simultaneous quantification of fexofenadine and pseudoephedrine was developed and validated with 500 microL human plasma using mosapride as an internal standard (IS). Following solid-phase extraction, the analytes were separated using an isocratic mobile phase on a reversed-phase column and analyzed by MS/MS in the multiple reaction monitoring mode using the respective [M+H]+ ions, m/z 502/466 for fexofenadine, m/z 166/148 for pseuoephedrine and m/z 422/198 for the IS. The method exhibited linear dynamic ranges of 1-500 ng/mL and 2-1000 ng/mL for fexofenadine and pseudoephedrine, respectively, in human plasma. The lower limits of quantification were 1 and 2 ng/mL with a relative standard deviation of less than 10% for fexofenadine and pseudoephedrine, respectively. Acceptable precision and accuracy were obtained for concentrations over the standard curve range. The total chromatographic run time was 2 min and more than 400 human plasma samples could be analyzed in one day by running the system overnight. The method is precise and sensitive enough for its intended purpose.     

Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry

A high-performance liquid chromatography/positive ion electrospray tandem mass spectrometry method for the simultaneous quantification of efavirenz, emtricitabine and tenofovir was developed and validated with 100 microL human plasma. Following solid-phase extraction, the analytes were separated using a gradient mobile phase on a reverse-phase column and analyzed by MS/MS in the multiple reaction monitoring mode using the respective [M + H]+ ions, m/z 316 to 168 for efavirenz, m/z 248-130 for emtricitabine and m/z 288-176 for tenofovir, m/z 482-258 for rosuvastatin (IS), m/z 260-116 for propranolol (IS). The method exhibited a 100-fold linear dynamic range for all the three analytes in human plasma (20-2000, 2-200 and 20-2000 ng/mL for efavirenz, emtricitabine and tenofovir respectively). The lower limit of quantification was 2 ng/mL for emtricitabine and 20 ng/mL for both efavirenz and tenofovir with a relative standard deviation of less than 11%. Acceptable precision and accuracy were obtained for concentrations over the standard curve range. The total chromatographic run time of 4 min for each sample made it possible to analyze more than 250 human plasma samples per day. The method is precise and sensitive enough for its intended purpose. The method is also successfully applied to quantify efavirenz, emtricitabine and tenofovir concentrations in a rodent pharmacokinetic study.     

Rapid and sensitive LC-MS/MS method for the determination of metoprolol in Beagle dog plasma with a simple protein precipitation treatment and its pharmacokinetic applications

A rapid LC-MS/MS method with good accuracy and sensitivity was developed and validated for the pharmacokinetics study of metoprolol (MP) in beagle dogs. The plasma samples were simply precipitated by methanol and then analyzed by LC-MS/MS. An Ultimate XB-C?? column (150 × 2.1 mm ID, 5 μm) was used for separation, with methanol-water containing 0.2% formic acid (65:35, v/v) as the mobile phase at a flow rate of 0.2 mL/min. Monitoring ions of MP and internal standard (hydroxypioglitazone) were m/z 268.1/115.6 and m/z 373.1/150.2, respectively. The linear range was 3.03-416.35 ng/mL with an average correlation coefficient of 0.9996, and the limit of quantification was 3.03 ng/mL. The intra- and inter-day precision was less than 15%. At low, middle and high concentrations, the recovery, the matrix effect and the accuracy was in the range of 76.06%-95.25%, 93.67%-104.19% and 95.20%-99.96% respectively. The method was applied for the pharmacokinetics study of MP tartrate tablets (50 mg). The AUC(0-t), T(max) and C(max) were respectively 919.88 ± 195.67 μg/L·h, 0.96 ± 0.33 h, 349.12 ± 78.04 ng/mL.     

Simultaneous quantification of oxysophocarpine and its active metabolite sophocarpine in rat plasma by liquid chromatography/mass spectrometry for a pharmacokinetic study

A sensitive, rapid and specific method for the simultaneous quantification of oxysophocarpine (OSC) and its active metabolite sophocarpine (SC) in rat plasma was developed and validated, using a liquid-liquid extraction procedure followed by liquid chromatography/electrospray ionization mass spectrometric (LC/ESI-MS) analysis. The separation was performed on a Zorbax Extend-C(18) column (2.1 mm i.d. x 50 mm, 5 microm) with a C(18) guard column using methanol-water containing 5 mm ammonium acetate (15:85, v/v) as mobile phase. Analysis was performed in selected ion monitoring (SIM) mode with an electrospray ionization (ESI) interface. [M + H](+) at m/z 263 for OSC, [M + H](+) at m/z 247 for SC and [M + H](+) at m/z 249 for matrine (internal standard) were selected as detecting ions, respectively. The method was linear in the concentration ranges 10-1000 ng/mL for OSC and 5-500 ng/mL for SC. The intra- and inter-day precisions (coefficient of variation) were within 7% for both analytes. Their accuracy (relative error) ranged from -6.4 to 1.5%. The limits of detection for OSC and SC were 3 and 1.5 ng/mL, respectively. The limits of quantitation for OSC and SC were 10 and 5 ng/mL, respectively. Recoveries of both analytes were greater than 85% at the low, medium and high concentrations. Both analytes were stable during all sample storage, preparation and analytic procedures. The method was successfully applied to a pharmacokinetic study after an oral administration of OSC to rats with a dose of 15 mg/kg.